Besides the analysis of PD-L1+ CTCs, a prospective exploratory cohort study (including 104 NSCLC patients receiving ICIs) investigated the predictive value of CTCs and tumor-derived extracellular vesicles. The gene discussed is CD274; the disease is non-small cell lung carcinoma.